[Federal Register Volume 71, Number 184 (Friday, September 22, 2006)]
[Notices]
[Pages 55499-55500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-8089]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse, Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Health Services Research Subcommittee.
    Date: October 4-5, 2006.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Madison Hotel, 1177--15th Street, NW., Washington, DC 
20005.
    Contact Person: Meenaxi Hiremath, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6101 Executive 
Blvd., Suite 220, MSC 8401, Bethesda, MD 20892, 301-402-7964, 
mh392G@nih. gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Medication Development Research Subcommittee.
    Date: October 4, 2006.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott at Metro Center, 775 12th Street, NW., 
Washington, DC 20005.
    Contact Person: Gerald L. McLaughlin, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC

[[Page 55500]]

8401, 6101 Executive Blvd., Bethesda, MD 20892-8401, 301-402-6226, 
<a href="/cdn-cgi/l/email-protection#41262c70757420012f28296f262e37"><span class="__cf_email__" data-cfemail="086f65393c3d6948666160266f677e">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Treatment Research Subcommittee.
    Date: October 4-5, 2006.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Madison Hotel, 1177--15th Street, NW., Washington, DC 
20005.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401, (301) 435-1432.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, E-Member Conflict Group A.
    Date: October 4, 2006.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Madison Hotel, 1177--15th Street, NW., Washington, DC 
20005.
    Contact Person: Mark R. Green, PhD, Deputy Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1431; <a href="/cdn-cgi/l/email-protection#4b262c392e2e257a0b25222f2a65252223652c243d"><span class="__cf_email__" data-cfemail="4b262c392e2e257a0b25222f2a65252223652c243d">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA/L Conflicts.
    Date: October 4, 2006.
    Time: 2 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott at Metro Center, 775 12th Street, NW., 
Washington, DC 20005.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, 301.435.1388, <a href="/cdn-cgi/l/email-protection#c0b2aca9b580aea9a4a1eeaea9a8eea7afb6"><span class="__cf_email__" data-cfemail="2c5e4045596c4245484d02424544024b435a">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, E-Member Conflict Group B.
    Date: October 4, 2006.
    Time: 4 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Madison Hotel, 1177 15th Street, NW., Washington, DC 
20005.
    Contact Person: Mark R. Green, PhD, Deputy Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1431, <a href="/cdn-cgi/l/email-protection#b8d5dfcaddddd689f8d6d1dcd996d6d1d096dfd7ce"><span class="__cf_email__" data-cfemail="97faf0e5f2f2f9a6d7f9fef3f6b9f9feffb9f0f8e1">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA-F Conflicts.
    Date: October 5, 2006.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Housing Center Events, 1201 15th Street, NW., 
Washington, DC 20005.
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401, 301-402-6626, <a href="/cdn-cgi/l/email-protection#3c5b510d08095d7c525554125b534a"><span class="__cf_email__" data-cfemail="e0878dd1d4d581a08e8988ce878f96">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Centers Review Committee.
    Date: October 23, 2006.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, 301-435-1388, <a href="/cdn-cgi/l/email-protection#91e3fdf8e4d1fff8f5f0bffff8f9bff6fee7"><span class="__cf_email__" data-cfemail="4537292c30052b2c21246b2b2c2d6b222a33">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Program Projects.
    Date: October 24, 2006.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, 301-435-1388, <a href="/cdn-cgi/l/email-protection#9eecf2f7ebdef0f7faffb0f0f7f6b0f9f1e8"><span class="__cf_email__" data-cfemail="7e0c12170b3e10171a1f5010171650191108">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: November 14-16, 2006.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Room 220, MSC 8401, 
Bethesda, MD 20892-8401, 301-415-4530, <a href="/cdn-cgi/l/email-protection#56333a602416383f3e78313920"><span class="__cf_email__" data-cfemail="4d28217b3f0d232425632a223b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program No. 93.279, Drug 
Abuse and Addiction Research Program, National Institutes of Health, 
HHS)

    Dated: September 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8089 Filed 9-21-06; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>